Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 Q1- Text added to 2019 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
airway, angioedema, antibody, billion, Cloud, CNS, commonly, corticosteroid, demolition, deposition, disclaim, encoding, HAE, Hereditary, hosting, investor, IPO, jointly, kallikrein, left, monogenic, Neurimmune, ophthalmologic, plasma, resumed, shorter, software, subretinal, subsidiary, surgery, swelling, tau, tolerability, unbilled, unregulated, upstream, vacate, vendor
Valuein 2019 Q1 filing- Value in 2019 Q2 filing
Original filings
Filing view